{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:30:02Z","timestamp":1792873802665,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.eclinm.2021.101005","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:24:23Z","timestamp":1626182663000},"page":"101005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-4830","authenticated-orcid":false,"given":"Rebecca","family":"McKetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyna","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan I.","family":"Lubman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina te","family":"Pas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Bathish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayle K.","family":"Raftery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wrobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Arunogiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.101005_bib0001","series-title":"World drug report 2017","first-page":"13","year":"2017"},{"key":"10.1016\/j.eclinm.2021.101005_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2013.12.025","article-title":"The global epidemiology and burden of psychostimulant dependence: findings from the global burden of disease study 2010","volume":"137","author":"Degenhardt","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.eclinm.2021.101005_bib0003","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: challenges and opportunities","volume":"394","author":"Farrell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101005_bib0004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eclinm.2019.09.014","article-title":"Mental health outcomes associated with of the use of amphetamines: a systematic review and meta-analysis","volume":"16","author":"McKetin","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2021.101005_bib0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(10)60753-2","article-title":"Amphetamine-group substances and HIV","volume":"376","author":"Colfax","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101005_bib0006","doi-asserted-by":"crossref","first-page":"e0234809","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: a systematic review of reviews","volume":"15","author":"Ronsley","year":"2020","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101005_bib0007","first-page":"CD011866","article-title":"Psychosocial interventions for psychostimulant misuse","volume":"9","author":"Minozzi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2021.101005_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: a systematic review and network meta-analysis","volume":"15","author":"De Crescenzo","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2021.101005_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0740-5472(03)00067-9","article-title":"DATStats: results from 85 studies using the drug abuse treatment cost analysis program","volume":"25","author":"Roebuck","year":"2003","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.eclinm.2021.101005_bib0010","first-page":"299","article-title":"Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys","volume":"16","author":"Degenhardt","year":"2017","journal-title":"World Psychiatry Off J World Psychiatr Assoc (WPA)"},{"key":"10.1016\/j.eclinm.2021.101005_bib0011","first-page":"CD003026","article-title":"Treatment for amphetamine psychosis.[update of Cochrane Database Syst Rev. 2008;(4):CD003026; PMID: 18843639]","author":"Shoptaw","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2021.101005_bib0012","first-page":"CD003021","article-title":"Treatment for amphetamine withdrawal","author":"Shoptaw","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2021.101005_bib0013","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1073858413520347","article-title":"Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis","volume":"20","author":"Scofield","year":"2014","journal-title":"The Neuroscientist"},{"key":"10.1016\/j.eclinm.2021.101005_bib0014","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.eclinm.2021.101005_bib0015","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2012.66","article-title":"N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study","volume":"37","author":"Schmaal","year":"2012","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1016\/j.eclinm.2021.101005_bib0016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/dar.12414","article-title":"A potential role for N-acetylcysteine in the management of methamphetamine dependence","volume":"36","author":"McKetin","year":"2017","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.eclinm.2021.101005_bib0017","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajad.12620","article-title":"N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis","volume":"26","author":"Duailibi","year":"2017","journal-title":"Am J addict"},{"key":"10.1016\/j.eclinm.2021.101005_bib0018","first-page":"28","article-title":"The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study","volume":"18","author":"Mousavi","year":"2015","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.eclinm.2021.101005_bib0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addbeh.2017.02.006","article-title":"Polysubstance use in treatment seekers who inject amphetamine: drug use profiles, injecting practices and quality of life","volume":"71","author":"Kelly","year":"2017","journal-title":"Addict Behav"},{"key":"10.1016\/j.eclinm.2021.101005_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101005_bib0021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/10826084.2018.1521430","article-title":"A systematic review of the symptom profile and course of methamphetamine associated psychosis","volume":"54","author":"Voce","year":"2019","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.eclinm.2021.101005_bib0022","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","article-title":"The profile of psychiatric symptoms exacerbated by methamphetamine use","volume":"161","author":"McKetin","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.eclinm.2021.101005_bib0023","unstructured":"Cetylev (TM) (acetylcysteine) effervescent tablets for oral solution [Full prescribing information]. 2016."},{"key":"10.1016\/j.eclinm.2021.101005_bib0024","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13063-019-3450-0","article-title":"A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (\u201cice\u201d) dependence","volume":"20","author":"McKetin","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.eclinm.2021.101005_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"A comprehensive psychopathological rating scale","author":"Asberg","year":"1978","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.eclinm.2021.101005_bib0026","first-page":"594","article-title":"Manual for the expanded brief psychiatric rating scale","volume":"12","author":"Lukoff","year":"1986","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.eclinm.2021.101005_bib0027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s001270050026","article-title":"The psychometric properties of the composite international diagnostic interview","volume":"33","author":"Andrews","year":"1998","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"Suppl 20","key":"10.1016\/j.eclinm.2021.101005_bib0028","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.eclinm.2021.101005_bib0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13063-019-3450-0","article-title":"A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (\u201cice\u201d) dependence","volume":"20","author":"McKetin","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.eclinm.2021.101005_bib0031","series-title":"Alcohol timeline followback (TLFB) users\u2019 manual","author":"Sobell","year":"1996"},{"key":"10.1016\/j.eclinm.2021.101005_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.11.004","article-title":"Measures of outcome for stimulant trials: ACTTION recommendations and research agenda","volume":"158","author":"Kiluk","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.eclinm.2021.101005_bib0033","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00952990.2011.598589","article-title":"Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037)","volume":"37","author":"Trivedi","year":"2011","journal-title":"Am J Drug Alcohol Abus"},{"key":"10.1016\/j.eclinm.2021.101005_bib0034","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.eclinm.2021.101005_bib0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/add.12472","article-title":"The craving experience questionnaire: a brief, theory-based measure of consummatory desire and craving","volume":"109","author":"May","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.eclinm.2021.101005_bib0036","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1440-1614.1999.00517.x","article-title":"Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure","volume":"33","author":"Srisurapanont","year":"1999","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0037","series-title":"MIMSOnline","year":"2021"},{"key":"10.1016\/j.eclinm.2021.101005_bib0038","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","article-title":"Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version II) among outpatient pharmacy consumers","volume":"8","author":"Atkinson","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.eclinm.2021.101005_bib0039","unstructured":"Medical Dictionary for Regulatory Activities (MedDRA\u00ae). Pharmacovigilance; 2006: 168-83."},{"key":"10.1016\/j.eclinm.2021.101005_bib0040","series-title":"Bootstrapping: a nonparametric approach to statistical inference","author":"Mooney","year":"1993"},{"key":"10.1016\/j.eclinm.2021.101005_bib0041","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1521-0391.2013.12034.x","article-title":"A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence","volume":"22","author":"LaRowe","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.eclinm.2021.101005_bib0042","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.[Erratum appears in Am J Psychiatry. 2012 Aug 1;169(8):869]","volume":"169","author":"Gray","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0043","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.drugalcdep.2017.04.020","article-title":"A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults","volume":"177","author":"Gray","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.eclinm.2021.101005_bib0044","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/YCO.0000000000000069","article-title":"Polysubstance use: diagnostic challenges, patterns of use and health","volume":"27","author":"Connor","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0045","first-page":"CD003974","article-title":"Placebo interventions for all clinical conditions","author":"Hr\u00f3bjartsson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eclinm.2021.101005_bib0046","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0047","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.25387","article-title":"Challenges of differential placebo effects in contemporary medicine: the example of brain stimulation","volume":"85","author":"Burke","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2021.101005_bib0048","doi-asserted-by":"crossref","first-page":"218ra5","DOI":"10.1126\/scitranslmed.3006175","article-title":"Altered placebo and drug labeling changes the outcome of episodic migraine attacks","volume":"6","author":"Kam-Hansen","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eclinm.2021.101005_bib0049","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0895-4356(01)00496-6","article-title":"What are the main methodological problems in the estimation of placebo effects?","volume":"55","author":"Hr\u00f3bjartsson","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2021.101005_bib0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jclinepi.2011.01.008","article-title":"Placebo effect studies are susceptible to response bias and to other types of biases","volume":"64","author":"Hr\u00f3bjartsson","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2021.101005_bib0051","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1098\/rstb.2010.0383","article-title":"Placebo interventions, placebo effects and clinical practice","volume":"366","author":"Linde","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.eclinm.2021.101005_bib0052","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0163278703026002002","article-title":"The use of placebo interventions in medical practice\u2014a national questionnaire survey of Danish clinicians","volume":"26","author":"Hr\u00f3bjartsson","year":"2003","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.eclinm.2021.101005_bib0053","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4088\/JCP.13m08454","article-title":"The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial","volume":"75","author":"Berk","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0054","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.2007.164.7.1115","article-title":"Is cocaine desire reduced by N-acetylcysteine?","volume":"164","author":"LaRowe","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eclinm.2021.101005_bib0055","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/0269881117730660","article-title":"The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Schulte","year":"2017","journal-title":"J Psychopharmacol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021002856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021002856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:09:00Z","timestamp":1762888140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":55,"alternative-id":["S2589537021002856"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101005","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101005"}}